Please assess the completion status of the following clinical trial:

Trial Title: A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* A male or female age between 18 and 64 years at the time of the first vaccination.~* non-childbearing female~Exclusion Criteria:~* Use of non-registered products~* Pregnancy~* Hypersensitivity to a previous dose of influenza vaccine~* Acute disease at the time of enrolment/vaccination.~* History of allergy or reactions likely to be exacerbated by any component of the vaccine~* Administration of any other influenza vaccine for the season 2006-2007~* Chronic disorders of the pulmonary or cardiovascular system, including asthma.~* Administration of immune-modifying drugs~* Administration of immunoglobulins and/or any blood products~* History of requiring regular medical follow-up or hospitalization during the preceding year because of chronic metabolic diseases (including diabetes mellitus), renal dysfunction, hemoglobinopathies, asthma or immunosuppression (including immunosuppression caused by medications or by human immunodeficiency virus)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).